DEFERASIROX
- Product NDC
- 59651-447
- 11-digit product format
- 596510447
- Labeler code
- 59651
- Product ID
- 59651-447_c220484e-1e6a-4a0c-a221-60223f3bc24c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DEFERASIROX
- Dosage form
- GRANULE
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA215137
- Marketing category
- ANDA
- Marketing start
- 2025-09-08
- Substance
- DEFERASIROX
- Active strength
- 90 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V8G4MOF2V9 | DEFERASIROX | 201530-41-8 | DEFERASIROX |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 59651-447-30 | 59651044730 | 30 PACKET in 1 CARTON (59651-447-30) / 1 GRANULE in 1 PACKET (59651-447-38) | 30 packet | 2025-09-08 | No | No | Historical |